Infectious Microbes & Diseases

Wolters Kluwer Health

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Infectious Microbes & Diseases is an open-access journal published by Wolters Kluwer Health in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,800 USD. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wolters Kluwer Health
ISSN
2641-5917
Country
United States
Languages
english
Access
Open access
Declared publication charge
1,800 USD
Articles in DOAJ
136
Declared review time
11 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-10-15
Indexing
DOAJ
APC
1,800 USD
Declared review time (DOAJ)
11 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

136

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

11weeks

Works in OpenAlex

213

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

18

i10-index

34

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2021-10-15
Added to DOAJ
2021-10-15
Declared plagiarism screening
Declared
Other fees beyond APC
No
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
98%
ORCID iDs in current deposits
6%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
IMDGanran Weishengwu yu jibingInfectious microbes and diseases
Source type
journal
NLM unique ID (PubMed)
9918351166506676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Infectious and parasitic diseases

LCC codes

RC109-216

Subject areas

  • Gut microbiota and health
  • Gut microbiota and health
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
Show all subjects (50)
  • Liver Disease Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Clostridium difficile and Clostridium perfringens research
  • Clostridium difficile and Clostridium perfringens research
  • HIV/AIDS Research and Interventions
  • HIV/AIDS Research and Interventions
  • Streptococcal Infections and Treatments
  • Bacterial Infections and Vaccines
  • Liver Disease and Transplantation
  • Liver Disease and Transplantation
  • Streptococcal Infections and Treatments
  • Bacterial Infections and Vaccines
  • HIV Research and Treatment
  • Hepatitis B Virus Studies
  • HIV Research and Treatment
  • Hepatitis B Virus Studies
  • Mycobacterium research and diagnosis
  • Mycobacterium research and diagnosis
  • Reproductive tract infections research
  • Virology and Viral Diseases
  • Reproductive tract infections research
  • Virology and Viral Diseases
  • COVID-19 epidemiological studies
  • COVID-19 epidemiological studies
  • Vibrio bacteria research studies
  • Vibrio bacteria research studies
  • Hepatitis C virus research
  • Antifungal resistance and susceptibility
  • Tuberculosis Research and Epidemiology
  • Antifungal resistance and susceptibility
  • Tuberculosis Research and Epidemiology
  • Antibiotic Use and Resistance
  • Long-Term Effects of COVID-19
  • Antibiotic Use and Resistance
  • Viral gastroenteritis research and epidemiology
  • HIV/AIDS drug development and treatment
  • Hepatitis C virus research
  • Long-Term Effects of COVID-19
  • Viral gastroenteritis research and epidemiology
  • HIV/AIDS drug development and treatment
  • Influenza Virus Research Studies
  • Influenza Virus Research Studies

Keywords (DOAJ)

  • vaccines
  • microbiology
  • infectious diseases
  • immunology
  • proteomics

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: